The aim of this study was to investigate the relationship between serum ferritin and diabetes mellitus (DM) in the Korean population. Methods: This cross-sectional study included 9,576 subjects (4,264 men, 2,394 pre-menopausal women, and 2,918 post-menopausal women) older than 19 years using data from the 2010-2012 Korean National Health and Nutrition Examination Survey. DM was defined as fasting plasma glucose ≥126 mg/dL, glycosylated hemoglobin ≥6.5%, or use of any glucose-lower medication including insulin therapy. Results: The overall prevalence of DM was 12.0, 3.6, and 17.3% in men, pre-menopausal women, and post-menopausal women, respectively. DM prevalence was greater with ferritin levels from Q1 to Q4: 10.3, 10.2, 12.7, and 14.8% in men; 2.0, 2.8, 2.8, and 6.4% in pre-menopausal women; and 13.9, 14.4, 18.1, and 22.9% in post-menopausal women, respectively. Compared with participants in Q1, the odds ratios (95% confidence intervals) for DM among participants in Q4 were 1.67 (1.20-2.32) in men, 2.06 (0.91-4.66) in pre-menopausal women, and 1.60 (1.09-2.35) in post-menopausal women after adjusting for age and other covariates. Conclusion: Serum ferritin concentration was positively associated with a higher risk of DM in adult men and post-menopausal women.
INTRODUCTION
In 2014, an estimated 422 million people worldwide were living with diabetes-roughly a four-fold increase over the past 35 years.
1) About 4.8 million Korean people (13.7%) aged 30 years or older had type 2 diabetes in 2014, based on fasting glucose level, and 25.0% of adults had prediabetes. 2) Diabetes mellitus (DM) is burdensome to health authorities because it is associated with a higher risk of cardiovascular, renal, neurological, metabolic, and other various chronic complications. 3) Ferritin, a ubiquitous intracellular protein that controls iron homeostasis, is a clinical biomarker for the diagnosis of iron deficiency and systemic inflammation. 4, 5) Several researchers have hypothesized that high iron stores cause pancreatic β-cell damage and insulin resistance through oxidative stress. 6, 7) Because, in addition to oxidative stress, low-grade chronic inflammation plays an important role in the etiology of DM, [8] [9] [10] inflammatory markers such as C-reactive protein (CRP) are considered risk factors for DM. Higher ferritin level may be related to greater inflammation and oxidative stress. We hypothesized that higher serum ferritin level was related to the development of DM through oxidative stress and inflammation.
However, there are still conflicting findings between serum ferritin level and the risk of DM in some epidemiological studies.
The aim of this study was to investigate the association between serum ferritin level and the prevalence of DM in the Korean adults based on data from the 2010-2012
Korean National Health and Examination Survey (KNH-ANES). 
METHODS

Study population
Definitions of diabetes mellitus, menopause, and life-style factors
We defined DM as follows: receiving treatment with a hypoglycemic medication (insulin or oral hypoglycemic agents) as determined from self-report questionnaires, fasting plasma glucose level ≥126 mg/dL, or HbA1c ≥6.5%.
The menopausal state was described as self-reported amenorrhea caused by natural or artificial menopause (e.g., induced by oophorectomy). Because mean ferritin level was significantly different according to sex and menopausal status, it was necessary to examine this association after stratification according to sex and menopausal status. Regular alcohol drinkers were defined as participants who drink alcohol more than twice a week. Smoking status was divided into current smokers and others (former and non-smokers).
Regular exercise was defined as exercise including walking for more than 30 minutes per day more than 4 days per week. High educational status was defined as graduation from college or more.
Statistical analysis
Sampling weights were used to account for the complex sampling method, thereby maintaining the degree of representation of the entire Korean population and avoiding biased estimates. All analyses were performed separately after stratifying to men, pre-menopausal women, and post-menopausal women.
Ferritin levels were categorized into four quartile groups for men, pre-menopausal women, and post-menopausal women-Q1: ≤68.3 ng/mL, Q2: 68.4-104.6 ng/mL, Q3:
104.7-158.5 ng/mL, and Q4 >158.5 ng/mL in men; Q1: ≤ 14.3 ng/mL, Q2: 14.4-27.3 ng/mL, Q3: 27.4-44.4 ng/mL, and Q4: >44.4 ng/mL in pre-menopausal women; and Q1:
≤36.5 ng/mL, Q2: 36.6-57.7 ng/mL, Q3: 57.8-87.3 ng/mL, and Q4: >87.3 ng/mL in post-menopausal women. In order to analyze the differences among the quartile groups of serum ferritin concentrations, general linear models for continuous variables and Chi-square tests for categorical variables were used. All data are presented as mean (or percentage)±standard error.
Logistic regression analyses were conducted to calculate the odds ratios (ORs) and 95% confidence intervals (CIs)
for DM prevalence according to ferritin quartile after adjusting for confounding variables that might confound the relationship between serum ferritin and incident diabetes, which include: age, BMI, systolic blood pressure, total cholesterol, WBC count, alcohol intake, smoking status, physical activity, and education level.
All analyses were performed using SAS statistical software, version 9.1 (SAS Institute Inc., Cary, NC, USA).
Statistical significance was determined at a P-value <0.05.
RESULTS
The participant characteristics by sex and menopausal status are presented in and P for trend <0.001). In pre-menopausal women, BMI and fasting plasma glucose level were greater with higher ferritin quartile, but HbA1C levels were similar. DM prevalence in pre-menopausal women was 2.0, 2.8, 2.8, and
6.4% for Q1 to Q4, respectively (P value <0.001 and P for trend <0.001). Like men, BMI, fasting plasma glucose, and
HbA1C levels were greater with greater ferritin quartile (all P values for trends <0.001) in post-menopausal women.
The percentage of DM in post-menopausal women was 13.9, 14.4, 18.1, and 22.9% for Q1 to Q4, respectively (P value <0.001 and P for trend <0.001).
We conducted logistic regression analyses in order to investigate the association between serum ferritin level and DM (Table 3) 
DISCUSSION
In this cross-sectional study, we found that higher serum ferritin concentration was associated with higher DM prevalence in adult men and post-menopausal women in a representative sample of the Korean population after adjusting for age, BMI, systolic blood pressure, total cholesterol, WBC count, alcohol intake, smoking, physical activity, and education.
The role of elevated serum ferritin concentration in type 2 diabetes has been investigated in several studies. Serum ferritin is a highly sensitive and reliable parameter used to evaluate body iron stores, 18) and it also reflects systemic inflammatory status and oxidative stress-mediated cellular damage. 5) Although the exact mechanism underlying the association between elevated serum ferritin concentration and DM is not clearly understood, it is thought that higher serum iron contributes to the development of diabetes by causing chronic low grade inflammation and oxidative stress. Under conditions of oxidative stress, a higher serum ferritin level may lead to iron-catalyzed formation of hydroxyl radicals and subsequent cellular or tissue damage, leading to insulin dysfunction, such as insulin resistance and abnormal pancreatic β-cell function. 13, 19) Insulin receptors and insulin receptor substrates (IRS) tend to be abnormally phosphorylated on serine or threonine residues instead of the typical tyrosine residue through 
